Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Lupin Gets U.S. FDA Approval for Tramadol Painkiller Pill

Nov. 2 (Bloomberg) -- Lupin Ltd., the world’s biggest maker of anti-tuberculosis medicines, received approval from the U.S. Food and Drug Administration for its tramadol pill, the generic version of Johnson & Johnson’s Ultram painkiller, according to a statement on the regulator’s website.

Link to Company News:{3400398Z US <Equity> CN <GO>} Link to Company News:{JNJ US <Equity> CN <GO>} Link to Company News:{LPC IN <Equity> CN <GO>}

To contact the reporter on this story: Adi Narayan in Mumbai at anarayan8@bloomberg.net

To contact the editor responsible for this story: Niveditha Ravi at nravi2@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.